Looking to balance out your exposure to IMVT? The ETFs below have the lowest correlation with IMVT — they tend to move on their own, which can help reduce risk when IMVT drops. The stock ideas table highlights individual companies that behave independently from IMVT.
Best Diversifiers for IMVT
1 ETFs have low correlation with IMVT (below 0.3), 0 of which are negatively correlated. The least correlated is VanEck Semiconductor ETF (SMH) (Semiconductors) with a 1Y correlation of 0.25, roughly unchanged from 0.28 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| VanEck Semiconductor ETF | 0.25 | 0.24 | 0.28 | 90 | Semiconductors, Technology Equities | IMVT vs SMH | |
| Vanguard S&P 500 ETF | 0.34 | 0.34 | 0.34 | 66 | S&P 500 | IMVT vs VOO | |
| SPDR S&P Biotech ETF | 0.71 | 0.63 | 0.61 | 93 | Health & Biotech Equities | IMVT vs XBI |
Low-Correlation Stock Ideas
If you're looking for individual stocks that move independently from IMVT, these are worth exploring. The table shows U.S. companies ($1B+ market cap) with low correlation to IMVT and solid risk/return profiles. The least correlated is Nasdaq, Inc. (NDAQ) (Financial Services) with a 1Y correlation of 0.15, roughly unchanged from 0.24 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Sector |
|---|---|---|---|---|---|---|
| Nasdaq, Inc. | 0.15 | 0.20 | 0.24 | 51 | Financial Services | |
| Madrigal Pharmaceuticals, Inc. | 0.34 | 0.31 | 0.35 | 79 | Healthcare | |
| Catalyst Pharmaceuticals, Inc. | 0.35 | 0.35 | 0.37 | 86 | Healthcare | |
| Rhythm Pharmaceuticals, Inc. | 0.35 | 0.36 | 0.38 | 55 | Healthcare | |
| Mirum Pharmaceuticals, Inc. | 0.38 | 0.35 | 0.31 | 94 | Healthcare |
To view more results, upgrade your current subscription plan.
Build a portfolio that complements IMVT
Add IMVT to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with IMVT